Real-World Study on the Efficacy of IBI-322 in Combination With Lenvatinib for the Treatment of Extensive Stage Small Cell Lung Cancer
Clinical trial NCT05991180 · UNKNOWN
Trial details
- NCT number
- NCT05991180
- Sponsor
- Hunan Province Tumor Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-25
- Primary completion
- 2024-12-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.